UMGCCC

To watch a livestream of Monday’s program, visit: mpt.org/programs/direc…

Monday at 7 p.m., tune in to @marylandpubtv's Your Health. UMMC gastroenterologist Dr. Ekta Gupta discusses the rise in colorectal cancer among younger adults, what may be driving it, and steps people can take to help reduce their cancer risk.

Ready for the #StomachCancer Patient Empowerment Summit hosted by @StoCANcer. Looking forward to a great day! #Gastric #CancerResearch @UMGCCC

WATCH 👀: Ranee Mehra, MD, of @UMGCCC discusses efficacy data for subcutaneous amivantamab plus pembrolizumab in HNSCC from multiple clinical trials. See the whole video here ➡️: hubs.li/Q045Y7-J0 #hncsm #oncology

Great way to close out #SSO2026 with 2 amazing presentations by Dr Rachael Belcher and ⁦@AmberFGallanis⁩ on #CDH1 research. ⁦@MarylandSurg⁩ ⁦@UMGCCC⁩

Rates of colorectal cancer are rising in young people. Hear more from Dr. Ekta Gupta, Chief of Gastroenterology at UMMC's Midtown Campus and Associate Professor of Medicine @UMmedschool, in @wbaltv11's story about risk factors and symptoms to look out for. wbaltv.com/article/colore…

Proud of our speakers at #ACRO2026 & #ACROSEAL 2026, expanding our department’s missions in sharing cutting-edge #radonc research and leadership skills! #RadiatingExcellence Dr. Jason Molitoris @JKMolitoris, Dr. Zak Rana @ZakieRana, Jamie LePage, Kimberly Simmons-Lee & Melissa Albright

The PrE0510 #ClinicalTrial, led by @teekayowo of @UMGCCC, aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with #SmallCellLungCancer. More: bit.ly/PrE0510 #LCSM #LungCancer #SCLC

Read the full Journal of the National Cancer Institute publication: pubmed.ncbi.nlm.nih.gov/41123288/ #CancerResearch

UMGCCC's Dr. Mark V. Mishra (@MarkMishraMD) is senior author of a recently published study that found a sizeable proportion of patients who experience neurocognitive function failure following brain radiation eventually attain full and sustained cognitive recovery.

Dr Yinin Hu - expert in Thyroid Cancer ⁦@UMGCCC⁩ and alumnus of ⁦@MSKCancerCenter⁩ is presenting on genomic testing in DTC. #SSO2026 ⁦⁦@MarylandSurgery⁩

Proud to support the Maryland Half Marathon & 5K on June 6 and the fight against cancer at @UMGCCC. Together, we make an impact. #MarylandHalfMarathon #5K #ThisIsWhyWeRun secure.ummsfoundation.org/site/PageServe…

WATCH: @RaneeMehra, of @UMGCCC, discusses the design of the OrigAMI-5 trial of pembrolizumab plus amivantamab and carboplatin for recurrent or metastatic HNSCC. #hncsm #oncology onclive.com/view/dr-mehra-…

📹Watch @RaneeMehra, of @UMGCCC, highlight the future of the HNSCC treatment paradigm! See our site for more head and neck cancer insights from Dr Mehra. #hncsm #oncology onclive.com/video-series/d…

WATCH: @RaneeMehra, of @UMGCCC, highlights how the ongoing OrigAMI-5 study may address an unmet need for patients with treatment-naive, recurrent or metastatic HNSCC. #hncsm #oncology onclive.com/view/dr-mehra-…

The PrE0510 #ClinicalTrial, led by @teekayowo of @UMGCCC, aims to determine the optimal dose of ivonescimab in combo with carboplatin & etoposide for patients with #SmallCellLungCancer. More: clinicaltrials.gov/study/NCT07057… #LCSM #LungCancer #SCLC

WATCH: @RaneeMehra, of @UMGCCC, discusses the toxicities associated with subcutaneous amivantamab in recurrent or metastatic HNSCC. #hncsm #Oncology onclive.com/view/dr-mehra-…

WATCH: @RaneeMehra, of @UMGCCC, discusses the efficacy of subcutaneous amivantamab plus pembrolizumab in patients with first-line recurrent or metastatic HNSCC. #hncsm #oncology onclive.com/view/dr-mehra-…

Celebrate our 10th anniversary with us! From being the first and only proton center in our region to treating more than 6,000 patients, we’re proud to help those on their cancer journey. Check out our video to see what’s been happening at MPTC for the last 10 years.

Appreciated the opportunity to present this data on behalf of my co- authors @UMGCCC